Evidence map›Paper›PMID 25153865›Full record

ReviewMolecules (Basel, Switzerland)2014

Trends in protein-based biosensor assemblies for drug screening and pharmaceutical kinetic studies.

Ana M Gonçalves, Augusto Q Pedro, Fátima M Santos, Luís M Martins, Cláudio J Maia, João A Queiroz, Luís A Passarinha

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Other Techniques.Advances in biochemical engineering/biotechnology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Special Issue: Enzyme Immobilization 2016.Molecules (Basel, Switzerland) · 2017
    Article
  9. Review
  10. Editorial: Special issue--Enzyme immobilization.Molecules (Basel, Switzerland) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana M GonçalvesCICS-UBI Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, 6201-506 Covilhã, Portugal. ggmargarida@gmail.com.
Augusto Q PedroCICS-UBI Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, 6201-506 Covilhã, Portugal. apedro@fcsaude.ubi.pt.
Fátima M SantosCICS-UBI Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, 6201-506 Covilhã, Portugal. ftxsantos@gmail.com.
Luís M MartinsCICS-UBI Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, 6201-506 Covilhã, Portugal. lmcmartins1@hotmail.com.
Cláudio J MaiaCICS-UBI Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, 6201-506 Covilhã, Portugal. cmaia@fcsaude.ubi.pt.
João A QueirozCICS-UBI Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, 6201-506 Covilhã, Portugal. jqueiroz@ubi.pt.
Luís A PassarinhaCICS-UBI Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, 6201-506 Covilhã, Portugal. lpassarinha@fcsaude.ubi.pt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The selection of natural and chemical compounds for potential applications in new pharmaceutical formulations constitutes a time-consuming procedure in drug screening. To overcome this issue, new devices called biosensors, have already demonstrated their versatility and capacity for routine clinical diagnosis. Designed to perform analytical analysis for the detection of a particular analyte, biosensors based on the coupling of proteins to amperometric and optical devices have shown the appropriate selectivity, sensibility and accuracy. During the last years, the exponential demand for pharmacokinetic studies in the early phases of drug development, along with the need of lower molecular weight detection, have led to new biosensor structure materials with innovative immobilization strategies. The result has been the development of smaller, more reproducible biosensors with lower detection limits, and with a drastic reduction in the required sample volumes. Therefore in order to describe the main achievements in biosensor fields, the present review has the main aim of summarizing the essential strategies used to generate these specific devices, that can provide, under physiological conditions, a credible molecule profile and assess specific pharmacokinetic parameters.

Indexed as

Biosensing TechniquesAnimalsDrug Evaluation, PreclinicalHumansImmobilized ProteinsLimit of DetectionNanocompositesImmobilized Proteins

Identifiers

PMID25153865
PMCPMC6270898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.